Search research articles
Contact Us
Filters
Showing results (51-60 of 96) with videos related to
Page
of 10
Sort By:
International Cancer Conference Journal
|
January 27, 2026
Pathological diagnosis and therapeutic management of hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cell carcinoma
Kojiro Tashiro, Yoji Nagashima, Mikiko Kaneko, et al.
Clinical Genitourinary Cancer
|
April 21, 2024
Radiographic Progression at Castration-Resistant Prostate Cancer Diagnosis: A Prognostic Indicator of Metastatic Hormone-Sensitive Prostate Cancer
Kojiro Tashiro, Shoji Kimura, Shunsuke Tsuzuki, et al.
International Journal of Clinical Oncology
|
July 11, 2023
Clinical characteristics of secondary bladder cancer developing after low-/high-dose-rate brachytherapy to treat localized prostate cancer
Keiichiro Miyajima, Hirotaka Suzuki, Fumihiko Urabe, et al.
Clinical Genitourinary Cancer
|
April 4, 2026
Clinical Characteristics and Predictive Factors of Symptomatic Skeletal Events in Patients With Metastatic Castration-Sensitive Prostate Cancer Treated With Denosumab
Yuzo Inaba, Fumihiko Urabe, Yu Imai, et al.
Urologic Oncology
|
October 8, 2025
Predicting recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: Development and validation of the JIKEI-YAYOI score
Yuya Iwamoto, Halle Foss, Yudai Ishiyama, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
July 20, 2024
Changes in the treatment landscape of metastatic hormone-sensitive prostate cancer following approval of upfront androgen receptor signaling inhibitors: A multicenter study
Fumihiko Urabe, Katsuki Muramoto, Takafumi Yanagisawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
May 16, 2025
Evaluation of Optimal Sequential Treatment Patterns and Clinical Outcomes in Patients With Advanced Urothelial Carcinoma Treated With First-Line Platinum-Based Chemotherapy: A Multicenter Collaborative Study
Fumihiko Urabe, Kojiro Tashiro, Yu Imai, et al.
The Prostate
|
April 9, 2025
Evaluating CRPC Definition: Comparing Upfront ARSI and Conventional Hormonal Therapy for Metastatic Hormone Sensitive Prostate Cancer (mHSPC) in Real World Propensity Score Matched Cohort
Tatsuya Shimomura, Fumihiko Urabe, Katsuki Muramoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
June 17, 2025
Risk Model for Lymph Node-Positive Prostate Cancer After Radical Prostatectomy
Kojiro Tashiro, Keiichiro Mori, Masaki Shiota, et al.
Prostate International
|
April 11, 2025
Comparative adverse event profiles of triplet therapy versus docetaxel-based therapy in patients with metastatic prostate cancer: a multicenter retrospective study
Fumihiko Urabe, Hirokazu Kagawa, Takafumi Yanagisawa, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 96) with videos related to
Sort By:
Page
of 10
International Cancer Conference Journal
|
January 27, 2026
Pathological diagnosis and therapeutic management of hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cell carcinoma
Kojiro Tashiro, Yoji Nagashima, Mikiko Kaneko, et al.
Clinical Genitourinary Cancer
|
April 21, 2024
Radiographic Progression at Castration-Resistant Prostate Cancer Diagnosis: A Prognostic Indicator of Metastatic Hormone-Sensitive Prostate Cancer
Kojiro Tashiro, Shoji Kimura, Shunsuke Tsuzuki, et al.
International Journal of Clinical Oncology
|
July 11, 2023
Clinical characteristics of secondary bladder cancer developing after low-/high-dose-rate brachytherapy to treat localized prostate cancer
Keiichiro Miyajima, Hirotaka Suzuki, Fumihiko Urabe, et al.
Clinical Genitourinary Cancer
|
April 4, 2026
Clinical Characteristics and Predictive Factors of Symptomatic Skeletal Events in Patients With Metastatic Castration-Sensitive Prostate Cancer Treated With Denosumab
Yuzo Inaba, Fumihiko Urabe, Yu Imai, et al.
Urologic Oncology
|
October 8, 2025
Predicting recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: Development and validation of the JIKEI-YAYOI score
Yuya Iwamoto, Halle Foss, Yudai Ishiyama, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
July 20, 2024
Changes in the treatment landscape of metastatic hormone-sensitive prostate cancer following approval of upfront androgen receptor signaling inhibitors: A multicenter study
Fumihiko Urabe, Katsuki Muramoto, Takafumi Yanagisawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
May 16, 2025
Evaluation of Optimal Sequential Treatment Patterns and Clinical Outcomes in Patients With Advanced Urothelial Carcinoma Treated With First-Line Platinum-Based Chemotherapy: A Multicenter Collaborative Study
Fumihiko Urabe, Kojiro Tashiro, Yu Imai, et al.
The Prostate
|
April 9, 2025
Evaluating CRPC Definition: Comparing Upfront ARSI and Conventional Hormonal Therapy for Metastatic Hormone Sensitive Prostate Cancer (mHSPC) in Real World Propensity Score Matched Cohort
Tatsuya Shimomura, Fumihiko Urabe, Katsuki Muramoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
June 17, 2025
Risk Model for Lymph Node-Positive Prostate Cancer After Radical Prostatectomy
Kojiro Tashiro, Keiichiro Mori, Masaki Shiota, et al.
Prostate International
|
April 11, 2025
Comparative adverse event profiles of triplet therapy versus docetaxel-based therapy in patients with metastatic prostate cancer: a multicenter retrospective study
Fumihiko Urabe, Hirokazu Kagawa, Takafumi Yanagisawa, et al.
Page
of 10